CSIMarket
 


Atyr Pharma Inc  (LIFE)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Atyr Pharma Inc's Quick Ratio

LIFE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




LIFE Quick Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Current Liabilities Change -57.39 % -54.62 % -32.08 % -13.31 % -6.53 %
Y / Y Cash & cash equivalent Change 1.62 % 1.75 % -5.04 % -2.27 % 15.83 %
Quick Ratio MRQ 11.38 5.4 4.5 4.23 4.77
Overall Ranking # # # # #
Seq. Current Liabilities Change -24.1 % -27 % -18.02 % -6.18 % -19.18 %
Seq. Cash & cash equivalent Change 59.79 % -12.33 % -12.76 % -16.85 % 60 %



Quick Ratio first quarter 2021 Comment
Atyr Pharma Inc's Cash & cash equivalent grew by 59.79 % in I. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Atyr Pharma Inc's Quick Ratio to 11.38, Quick Ratio remained below Atyr Pharma Inc average.

Within Biotechnology & Drugs industry 51 other companies have achieved higher Quick Ratio than Atyr Pharma Inc in first quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are LIFE Segments?
See Quick Ratio LIFE on the trailing twelve month basis
Quick Ratio first quarter 2021 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 52
Healthcare Sector # 186
Overall Market # 340


Quick Ratio Statistics
High Average Low
12.4 3.32 0.17
(Sep 30 2015)   (Dec 31 2012)




Financial Statements
Atyr Pharma Inc's Current Liabilities $ 4 Millions Visit LIFE's Balance sheet
Atyr Pharma Inc's Cash & cash equivalent $ 51 Millions Visit LIFE's Balance sheet
Source of LIFE's Sales Visit LIFE's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2021, within Biotechnology & Drugs Industry Quick RatioMar 31 2021 MRQ Cash & cash equivalentMar 31 2021 MRQ Current Liabilities
Assembly Biosciences inc   29.76 $ 214.884  Millions$ 7.221  Millions
Iteos Therapeutics Inc   27.17 $ 321.385  Millions$ 11.830  Millions
Solid Biosciences Inc   26.88 $ 268.497  Millions$ 9.988  Millions
Cocrystal Pharma Inc   26.58 $ 33.328  Millions$ 1.254  Millions
Vitality Biopharma Inc   26.44 $ 0.884  Millions$ 0.033  Millions
Protara Therapeutics Inc   26.19 $ 84.345  Millions$ 3.221  Millions
Denali Therapeutics Inc   25.88 $ 1,413.148  Millions$ 54.610  Millions
Satsuma Pharmaceuticals Inc   24.89 $ 133.120  Millions$ 5.349  Millions
Vistagen Therapeutics Inc   24.61 $ 103.108  Millions$ 4.189  Millions
Curis Inc   24.51 $ 156.413  Millions$ 6.382  Millions
Rubius Therapeutics inc   23.31 $ 330.650  Millions$ 14.185  Millions
Arca Biopharma Inc   23.24 $ 66.933  Millions$ 2.880  Millions
Aptose Biosciences Inc   23.16 $ 112.082  Millions$ 4.839  Millions
89bio Inc   22.42 $ 189.625  Millions$ 8.459  Millions
Igm Biosciences Inc   22.38 $ 331.674  Millions$ 14.818  Millions
Diffusion Pharmaceuticals Inc   22.07 $ 46.635  Millions$ 2.113  Millions
Allovir Inc   21.74 $ 336.992  Millions$ 15.500  Millions
Crispr Therapeutics Ag  21.74 $ 1,806.203  Millions$ 83.090  Millions
Immunovant Inc   21.32 $ 400.146  Millions$ 18.771  Millions
Adverum Biotechnologies Inc   20.28 $ 404.018  Millions$ 19.923  Millions
Oncternal Therapeutics Inc   20.04 $ 111.211  Millions$ 5.550  Millions
Forma Therapeutics Holdings Inc   19.97 $ 633.054  Millions$ 31.700  Millions
Jounce Therapeutics inc   19.92 $ 257.478  Millions$ 12.925  Millions
Salarius Pharmaceuticals inc   19.57 $ 36.612  Millions$ 1.871  Millions
4d Molecular Therapeutics Inc   18.67 $ 259.865  Millions$ 13.916  Millions
Aerpio Pharmaceuticals Inc   18.66 $ 39.009  Millions$ 2.090  Millions
Relay Therapeutics Inc   18.17 $ 262.720  Millions$ 14.460  Millions
Kymera Therapeutics Inc   17.39 $ 333.537  Millions$ 19.177  Millions
Revolution Medicines Inc   15.58 $ 681.593  Millions$ 43.759  Millions
Dyadic International Inc  15.55 $ 27.233  Millions$ 1.751  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TPCS's Profile

Stock Price

TPCS's Financials

Business Description

Fundamentals

Charts & Quotes

TPCS's News

Suppliers

TPCS's Competitors

Customers & Markets

Economic Indicators

TPCS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071